Tablo Sales Boost Outset Bottom Line
Product revenues increased 5.5% and service revenues increased in Q3 of 2022 over 2021. The Tablo is used for acute and home HD, and Outset won a 5-year VA contract for Tablo in hospitals and homes.
Read the full article » | Posted 12-19-2022
Related Articles
- ISPD’s Spotlight Webinar Series 2026 Posted 03-12-2026
- Dr. Brigitte Schiller Shares Thoughts on Prescribing Nocturnal Home HD Posted 03-12-2026
- Dr. Chris Chan and Dr. Klement Yeung: Treat Home HD as an Established Modality Posted 03-12-2026
- How to Get Started: Your Path to Home Dialysis – New AKF Webinar Posted 03-12-2026

